Literature DB >> 28090060

Medullary Nephrocalcinosis in a Furosemide Abuser.

Nobutaka Hirooka1, Mai Tahara, Koichi Takebayashi.   

Abstract

Entities:  

Year:  2017        PMID: 28090060      PMCID: PMC5337475          DOI: 10.2169/internalmedicine.56.7704

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 31-year-old woman with a long history of furosemide abuse presented with abdominal pain. She had been using furosemide (>200 mg per day) for at least the last 15 years. She initially used furosemide to maintain her urinary volume and later for weight loss. Her abdominal pain was caused by paralytic ileus due to hypokalemia (2.1 mEq/L). Although abdominal and pelvic CT revealed no intestinal obstruction, bilateral nephrocalcinosis was observed (Picture 1, 2). The pattern of nephrocalcinosis was diffuse throughout the medullary pyramids. Her estmated glomerular filtration rate (eGFR) was normal (119.4 mL/min./1.73 m2). Gout, hyper-parathyroidism and other etiologies may cause nephrocalcinosis (1); however, there was no clinical evidence of these conditions. No hypercalciuria was observed. Although the risk of developing nephrocalcinosis is higher in premature infants, it can be caused by the long-term abuse of furosemide in adults (2). She was discharged from hospital after undergoing medical treatment for ileus and hypokalemia.
Picture 1.
Picture 2.
  2 in total

1.  Medullary nephrocalcinosis associated with long-term furosemide abuse in adults.

Authors:  Y G Kim; B Kim; M K Kim; S J Chung; H J Han; J A Ryu; Y H Lee; K B Lee; J Y Lee; W Huh; H Y Oh
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

2.  Renal calcification incidence in very low birth weight infants.

Authors:  J S Jacinto; H D Modanlou; M Crade; A A Strauss; S K Bosu
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.